NEW DELHI: A DRDO lab has been successful in developing a drug, with its trial results showing faster recovery of hospitalised Covid- 19 patients.
The drug (2-deoxy- D-glucose (2-DG) has got the approval of Drugs Controller General of India (DCGI) After the a three-phase trial.
The Ministry of Defence said: “Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RTPCR negative conversion. The drug will be of immense benefit to people suffering.”